"De novo" cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!

Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101827. doi: 10.1016/j.clinre.2021.101827. Epub 2021 Nov 3.

Abstract

We report a rare and very late case of de novo cholangiocarcinoma in a patient transplanted for primary sclerosing cholangitis. An exhaustive analysis of the literature and of our case highlight the very poor prognosis of this type of tumor due to the delay in diagnosis and the potential value of a six-monthly MRI surveillance as soon as cholangitis recurs, but also in the presence of chronic digestive inflammation, whatever the mechanism.

Keywords: De novo cholangiocarcinoma; Liver transplant; Primary sclerosing cholangitis.

Publication types

  • Case Reports

MeSH terms

  • Bile Duct Neoplasms* / pathology
  • Bile Ducts, Intrahepatic / pathology
  • Cholangiocarcinoma* / diagnosis
  • Cholangiocarcinoma* / epidemiology
  • Cholangiocarcinoma* / etiology
  • Cholangitis, Sclerosing* / pathology
  • Humans
  • Liver Transplantation* / adverse effects
  • Neoplasm Recurrence, Local / pathology